medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2023, Number 2

<< Back Next >>

Rev Latin Infect Pediatr 2023; 36 (2)

Evolution and budget impact of possible improvements in the Immunization Programme: Uruguay 2007-2017

Olivera I, Grau C, Lazarov L, Dibarboure H, López JG, Oddo C, Bianculli P

Language: Spanish
References: 12
Page: 57-64
PDF size: 236.68 Kb.


ABSTRACT

Introduction: national vaccination programmes present a comprehensive approach that aims to reduce or suppress the consequences of immunopreventable diseases. The aim of the study was to evaluate the progress of the National Vaccination Plan (NVP) in Uruguay, its expenditure and to estimate the budgetary impact of using the quadrivalent influenza vaccine (QIV) to replace the trivalent influenza vaccine (TIV). Material and methods: the evolution of Uruguay's NVP 2007-2017 was assessed. A current scenario (TIV) and an alternative scenario (QIV) were defined. The results were expressed as the total budgetary impact, relative to the QIV scenario versus TIV in 2017. Results: in the period, Uruguay increased its NVP expenditure 3.4 times. Spending on vaccines per person-year in Uruguay reached 2.56 million USD. The modification in the QIV vaccination schedule could generate an increase of 12% (1 million USD) in the 2017 budget. Conclusions: first budget impact analysis study to be conducted in Uruguay with the objective of estimating the budgetary impact in this case of the transition from TIV to QIV. These results are essential to support local and regional health systems in their decision-making related to vaccination.


REFERENCES

  1. Sindicato Médico del Uruguay. Los médicos y las epidemias. 2009.

  2. Ministerio de Salud Pública de Uruguay. Certificado Esquema de Vacunación 2015. 2015 [Internet]. Disponible en: http://www.msp.gub.uy/noticia/vacunas

  3. Sociedad Uruguaya de Pediatría. Recomendaciones para Vacunación [Internet]. Disponible en: http://www.sup.org.uy/boletines/include/Recomendaciones/Vacunas.asp

  4. Ministerio de Salud Pública. Esquemas de Vacunación en Uruguay 1992-2019. Disponible en: https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/vacunas

  5. Organización Panamericana de la Salud. Año de introducción de vacunas-OPS/OMS. Disponible en: https://www.paho.org/es/documentos/ano-introduccion-vacunas.

  6. World Health Organization. Vaccines and Biologicals. Principios y consideraciones para agregar una vacuna al programa nacional de inmunización: de la decisión a la implementación y el monitoreo. 2014.

  7. World Health Organization. World Health Organization. Vaccines against influenza. WHO position paper. 2012; 87: 461-476.

  8. Banco Mundial. GDP (Current US$) - Uruguay | Data. Disponible en: https://data.worldbank.org/indicator/NY.GDP.MKTP.CD?locations=UY

  9. Organización Panamericana de la Salud & Organización Mundial de la Salud. Fondo Rotatorio de la Organización Panamericana de la Salud [Internet]. Disponible en: https://www.paho.org/es/documentos/folleto- fondo-rotatorio-ops

  10. Banco Mundial. Current health expenditure (% of GDP) - Uruguay | Data. Disponible en: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=UY.

  11. Pitrelli A. Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis. J Prev Med Hyg. 2016; 57: E34-40.

  12. Ruiz-Palacios GM, Beigel JH, Guerrero ML, et al. Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico. Hum Vaccin Immunother. 2020; 16: 827-835.




2020     |     www.medigraphic.com